"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh ...

Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

1,3-4* “We are making history with the bold innovation of PRECISION7,” said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. “Now, patients can start and end every ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with ...

Moreover, Alcon’s market share gains in the contact lens segment and upcoming product launches like PanOptix Pro and Unity are promising. Saxon also points to the forthcoming Capital Markets Day as a ...

"We are making history with the bold innovation of PRECISION7," said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. "Now, patients can start and end every week fresh with ...

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Greetings and welcome to the Alcon third quarter 2024 earnings conference ... Precision7 is a new one-week replacement contact lens that provides 16 hours of outstanding comfort and precise ...

Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...

Alcon also saw headwinds in its vision care division due to declines in contact lens care in its international markets. The unit posted 7% sales growth, below a consensus of 8.5%. The company's New ...